Antimicrobial Wound Dressings Market Size & Share, by Product (Silver Dressings, Povidone-iodine Dressings, PHMB Dressings); Application (Chronic Wounds, Acute Wounds); End-use (Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2856
  • Published Date: Apr 30, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Antimicrobial Wound Dressings Market size is poised to reach USD 5 Billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of antimicrobial wound dressing was USD 2 Billion. The market is expanding due to the rising prevalence of chronic wounds. For instance, it is speculated that over 13 million people worldwide suffer from chronic wounds each year, with the number of sufferers increasing as the population ages.

Antibacterial wound dressings contain agents or compounds with antibacterial characteristics, such as silver, iodine, and PHM. Antimicrobial wound dressings, which act as a barrier against microorganisms, can minimize the risk of infection and facilitate healing. Therefore, the global frequency of chronic wounds is predicted to rise, increasing the demand for antimicrobial wound dressings.

In addition to this, the antimicrobial wound dressings market is observing tremendous growth owing to the improved understanding of the wound healing process and technological advancements, there have been noteworthy advances in wound treatment. Along with this, dressings made from natural and synthetic sources are currently gaining popularity. Plant extracts have been successfully studied in injectable forms for adult stem cell therapies, and they have been shown to aid in skin regeneration when used in dressings.


Antimicrobial Wound Dressings Market
Get more information on this report: Request Free Sample PDF

Antimicrobial Wound Dressings Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing surgical interventions - Surgical treatments, both elective and emergency, increase demand for wound products, such as antimicrobial dressings. The increase in surgical treatments, particularly in fields such as orthopedics and cardiovascular surgery, helps to drive antimicrobial wound dressings market growth. Following surgical operations, patients are frequently left with surgical wounds that require adequate care and management to promote healing and prevent infection.

    Antimicrobial wound dressings are vital for this reason because they help to maintain a clean environment around the wound, lowering the incidence of surgical site infections (SSIs). As a result, the market for antimicrobial wound dressings has grown.
  • Increasing geriatric population - Chronic wounds, such as pressure ulcers and venous leg ulcers, become more common as the population ages. Older persons are more vulnerable to chronic wounds for a variety of reasons, including limited mobility, impaired circulation, and comorbidities including diabetes and cardiovascular disease. As a result, antimicrobial wound dressings are becoming more widely used.

    According to a report, the proportion of persons aged 65 and up is growing faster than those under that age. This means that the proportion of the global population aged 65 and more is predicted to climb from 10% in 2022 to 16% by 2050. Therefore, the increasing geriatric population is influencing the market growth.
  • Surge in the adoption of advanced wound dressing technologies - The market for antimicrobial wound dressings is just as dynamic as any other. Wound dressings have evolved, including innovative technologies such as smart sensors and microelectronics. These technologies allow for continuous monitoring of the wound healing process and infection status, delivering real-time data to healthcare providers.

    Furthermore, the industry's leading players are continually launching new products, fueling market growth. For instance, Convatec has launched ConvaFoam™ in the US, offering improved foam dressings for healthcare practitioners and patients. ConvaFoam™ is a versatile dressing that may be applied to many wound types at any point of the healing process, making it the ideal solution for wound management and skin protection.

Challenges

  • High costs of the product - Antimicrobial wound dressings are typically more expensive than regular wound dressings. The additional cost can be prohibitive for healthcare systems and people, particularly in areas with limited healthcare budgets. As a result, the antimicrobial wound dressings market may experience a decline.
  • Reduced healthcare spending in developing nations may hinder market growth
  • Inaccessible treatment for a large number of patients may act as a market restrain

Antimicrobial Wound Dressings Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

7%

Base Year Market Size (2023)

USD 2 Billion

Forecast Year Market Size (2036)

USD 5 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Antimicrobial Wound Dressings Segmentation

Application (Chronic Wounds, Acute Wounds)

The chronic wounds segment in the antimicrobial wound dressings market is estimated to gain the largest revenue share of about 58% in the year 2036. The dominance can be linked to an increase in the number of persons suffering from chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other types. Diabetes, cancer, and other autoimmune illnesses are expected to increase the incidence rate of chronic wounds all over the world. Diabetes risk factors include age, diet, physical activity, obesity, and genetics.

High blood sugar levels, poor circulation, immune system issues, and nerve damage can all increase the risk of developing a chronic wound, such as a diabetic foot ulcer. For instance, approximately 25% of patients with diabetes will develop a foot ulcer. A foot ulcer is the starting point for 85% of diabetic amputations.

Also, neuropathy, peripheral arterial disease (PAD), deformities, and Charcot's foot are all risk factors for developing diabetic foot ulcers. Therefore, these factors are boosting the growth of the market in this segment.

Product (Silver Dressings, Povidone-iodine Dressings, PHMB Dressings)

The silver dressings segment is predicted to hold a substantial share of 50% during the forecast timeline. The segment’s growth is driven by growing demand for the treatment of infections and wounds. Silver wound dressings are antimicrobial wound dressings using silver as an active ingredient. The dressing acts by releasing silver ions, which help to kill or inhibit the development of bacteria in the wound bed.

In the treatment of chronic wounds that are prone to infection, such as pressure ulcers and diabetic foot ulcers, silver wound dressing is helpful. They are also used to treat surgical wounds, lowering the risk of infection and promoting speedier recovery. Therefore, these factors are impacting the growth of the silver dressing segment.

Our in-depth analysis of the market includes the following segments:

     Product

  • Silver Dressings
  • Povidone-iodine Dressings
  • PHMB Dressings

     Application

  • Chronic Wounds
  • Acute Wounds

     End-use

  • Hospitals
  • Outpatient Facilities
  • Home Care
  • Research & Manufacturing

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Antimicrobial Wound Dressings Industry - Regional Synopsis

North America Market Statistics

Antimicrobial Wound Dressings market in the North America, amongst the market in all the other regions, is set to hold the largest with a share of about 37% by the end of 2036. The market growth in the region is also expected on account of a large aging population, increased wound and injury rates, and a high incidence of diabetes. According to a report, chronic wounds afflict around 8.2 million people in the United States every year.

Additionally, the region’s market is predicted to expand due to rising healthcare costs and expanded government support and reimbursement schemes for goods. Moreover, North America has well-established healthcare legislation and infection control requirements, making antimicrobial dressings an appealing option for healthcare professionals. These criteria place a high priority on avoiding surgical site infections, pressure ulcers, and other problems that can be treated with antimicrobial dressings.

APAC Market Analysis

The APAC region will also witness gigantic growth for the antimicrobial wound dressings market during the forecast period and will hold the second position owing to the expanding population in the region. Furthermore, medical tourism and an increase in severe wounds are major factors augmenting the market growth in the region. Antimicrobial wound dressings may also become more popular as chronic diseases and surgical cases increase in the Asia-Pacific region.

Research Nester
Antimicrobial Wound Dressings Market   size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Antimicrobial Wound Dressings Landscape

    • Bactiguard
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Medline Industries
    • Smith & Nephew
    • Cardinal Health
    • Convatec, Inc.
    • B. Braun SE
    • Coloplast Corp.
    • McKesson Corporation
    • Paul Hartmann AG
    • 3M

In the News

  • Bactiguard announced the debut of its wound offering in the United Kingdom and Ireland, in conjunction with Quintess Medical and their full-service medical sales and distribution partner, GS Medical. The agreement will not only expand Bactiguard's wound-care product line to reach more patients and end-users but will also boost Bactiguard's position in the wound-care industry. The UK wound market was valued at roughly GBP 860 million in 2022 and is predicted to expand in the future years.
  • Medline, the industry leader in skin care, unveiled the latest addition to its advanced wound portfolio, the OptiView® Transparent Dressing with HydroCore™ Technology. This unique clear wound dressing allows caregivers to quickly and easily inspect, monitor, and blanch skin while the covering is in place.

Author Credits:  Radhika Pawar


  • Report ID: 2856
  • Published Date: Apr 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of barge transportation was over USD 2 billion.

The market size for barge transportation is projected to cross USD 5 billion by the end of 2036 expanding at a CAGR of 7% during the forecast period i.e., between 2024-2036.

The major players in the market are Bactiguard, Medline Industries, Smith & Nephew, Cardinal Health, Convatec, Inc., B. Braun SE, Coloplast Corp., McKesson Corporation, Paul Hartmann AG, 3M, and others.

In terms of application, the chronic wounds segment is anticipated to account for the largest market share of 58% during 2024-2036.

The North America antimicrobial wound dressings sector is poised to hold the highest share of 37% by 2036.
Antimicrobial Wound Dressing Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample